Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07463105
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of chronic low back pain lasting at least 3 months
* Average pain intensity ≥4/10 during the previous week on the Numeric Rating Scale (NRS)
* Age between 40 and 65 years
* Ability to walk independently without assistive devices
* Functional disability related to low back pain defined as Oswestry Disability Index (ODI) ≥15%
* No contraindications to participation in a physiotherapy program or virtual reality training
* Ability to understand study procedures and follow instructions
* Written informed consent to participate in the study
Exclusion Criteria:
* Acute low back pain or pain lasting less than 3 months
* Neurological, orthopedic, rheumatological, oncological diseases or active inflammatory conditions that may affect study outcomes
* Cognitive impairment limiting the ability to understand instructions or participate in rehabilitation
* Contraindications to virtual reality training such as severe dizziness, nausea, epilepsy, or severe visual or auditory impairment
* Contraindications to body composition analysis (e.g., implanted cardiac pacemaker or other electronic implants)
* Unstable medical condition or uncontrolled cardiovascular or respiratory disorders preventing participation in rehabilitation
* Participation in other rehabilitation programs during the study period
* Failure to complete the four-week rehabilitation program
* Lack of written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Maximum Age:
65 Years
Study:
NCT07463105
Study Brief:
Protocol Section:
NCT07463105